Clinical Linkage of COVID-19 with Hypertension, Diabetes and Cardiovascular Disease

Abstract

            The coronavirus outbreak caused by the pandemic Coronavirus Disease (COVID-19) is heart-rending millions live around the globe, and it is the foremost major human tragedy in history. World Health Organization (WHO) declared the coronavirus disease (COVID-19) a pandemic and global outbreak with a severe public health concern. This outbreak caused by a novel infectious coronavirus of Severe Acute Respiratory Syndrome Coronavirus- 2 (SARS-CoV-2) sequences leading to an emergent crisis with significant loss of health and global economy. COVID-19 is more prone to exacerbate health concerns in hypertensive, diabetes, and cardiovascular disease patients, however, COVID-19 incidence outcomes are inconsistent. Prevention and control of the outbreak are very challenging due to the complex nature of the virus and its pathogenesis. WHO, CDC, and every national health authority are taking necessary actions to combat the contagious novel infection. The purpose of the review is to discuss potential mechanisms and clinical linkages between high blood pressure, diabetes, cardiovascular diseases, and SARS-CoV-2. We hope that we can identify information deficiencies that need more review and clinical evidence of the COVID-19 for hypertension and cardiovascular problems in patients with diabetes. This article will provide a comprehensive integrative strategy to control and manage of current outbreak and related mortality around the world.